{"id":31241,"date":"2025-04-03T18:54:18","date_gmt":"2025-04-03T10:54:18","guid":{"rendered":"https:\/\/flcube.com\/?p=31241"},"modified":"2025-04-03T18:54:19","modified_gmt":"2025-04-03T10:54:19","slug":"yuewei-medtech-secures-rmb100-million-in-series-a-funding-for-cardiac-device-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31241","title":{"rendered":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development"},"content":{"rendered":"\n<p>Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.<\/p>\n\n\n\n<p><strong>Company Background<\/strong><br>Founded in 2021, Yuewei Medtech has established a strong presence in China&#8217;s medical device sector. The company is recognized for its portfolio of leading products, which include next-generation cardiac stabilizers, a vascular anastomosis quality control system, and a coronary heart disease scoring system.<\/p>\n\n\n\n<p><strong>Funding Utilization<\/strong><br>The proceeds from this financing round will be strategically used to advance the development of novel medical devices aimed at improving diagnostic accuracy and treatment outcomes for coronary heart disease. Furthermore, the company is committed to enhancing its market reach by promoting its existing product line, which has already gained significant traction in the domestic market.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":31243,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[20,3972],"class_list":["post-31241","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-finance","tag-yuewei-medical-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31241\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development\" \/>\n<meta property=\"og:description\" content=\"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31241\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T10:54:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-03T10:54:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development\",\"datePublished\":\"2025-04-03T10:54:18+00:00\",\"dateModified\":\"2025-04-03T10:54:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0319-png.webp\",\"keywords\":[\"Finance\",\"Yuewei Medical Technology\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31241#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31241\",\"name\":\"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0319-png.webp\",\"datePublished\":\"2025-04-03T10:54:18+00:00\",\"dateModified\":\"2025-04-03T10:54:19+00:00\",\"description\":\"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31241\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0319-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0319-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"Yuewei Medical Technology Series A++ Funding Coronary Heart Disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31241#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development - Insight, China&#039;s Pharmaceutical Industry","description":"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31241","og_locale":"en_US","og_type":"article","og_title":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development","og_description":"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.","og_url":"https:\/\/flcube.com\/?p=31241","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-03T10:54:18+00:00","article_modified_time":"2025-04-03T10:54:19+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31241#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31241"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development","datePublished":"2025-04-03T10:54:18+00:00","dateModified":"2025-04-03T10:54:19+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31241"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31241#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","keywords":["Finance","Yuewei Medical Technology"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31241#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31241","url":"https:\/\/flcube.com\/?p=31241","name":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31241#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31241#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","datePublished":"2025-04-03T10:54:18+00:00","dateModified":"2025-04-03T10:54:19+00:00","description":"Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31241#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31241"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31241#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","width":1080,"height":608,"caption":"Yuewei Medical Technology Series A++ Funding Coronary Heart Disease"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31241#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0319-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31241"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31241\/revisions"}],"predecessor-version":[{"id":31244,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31241\/revisions\/31244"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31243"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}